A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease
Claudia H. Kawas(University of California, Irvine), E. Jeffrey Metter(Johns Hopkins University), C. Bacal(Johns Hopkins University), Susan M. Resnick(National Institute on Aging), María M. Corrada(University of California, Irvine), Ron Brookmeyer(University of California, Los Angeles), Anthony Morrison(Johns Hopkins University), D. Donnell Lingle(Johns Hopkins University), Alan B. Zonderman(National Institute on Aging)
Cited by 966
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report
|Brain|2019|1.6k
Hearing Loss and Incident Dementia
|Archives of Neurology|2011|1.5k
Longitudinal Magnetic Resonance Imaging Studies of Older Adults: A Shrinking Brain
|Journal of Neuroscience|2003|1.4k
Effects of Testosterone Treatment in Older Men
|New England Journal of Medicine|2016|864